Biosimilar Newsletter Archive

41. 05.16.24 -- Integrating Quality Processes And Documentation After A Merger 5/16/2024
    05/16/24 Biosimilar Development Newsletter
42. 05.14.24 -- Let's deviate from deviations - Sterile drugs. 5/14/2024

    05/14/24 Biosimilar Development Newsletter

43. 05.09.24 -- Sandoz, Amgen Resolve Denosumab Patent Litigation 5/9/2024
    05/09/24 Biosimilar Development Newsletter
44. 05.02.24 -- Designing Highly Agile Biopharma Manufacturing Facilities 5/2/2024
    05/02/24 Biosimilar Development Newsletter
45. 04.25.24 -- How Continuous Manufacturing Is Shaping Biopharma 4/25/2024
    04/25/24 Biosimilar Development Newsletter
46. 04.23.24 -- Novel Approaches In Chromatography Process Development 4/23/2024

    04/23/24 Biosimilar Development Newsletter

47. 04.18.24 -- Optimizing Drug Delivery Systems For Complex Biologics 4/18/2024

    04/18/24 Biosimilar Development Newsletter

48. 04.18.24 -- Fine-Tuning Analytical Development Strategies For Every Phase 4/18/2024
    04/18/24 Biosimilar Development Newsletter
49. 04.17.24 -- Leverage Innovative Assays And Monitoring To Improve mAb Production 4/17/2024

    04/17/24 Biosimilar Development Newsletter

50. 04.14.24 -- Proactive BioPharma Supplier Management 4/14/2024
    04/14/24 Biosimilar Development Newsletter